Ocathepsin Activators comprise a range of compounds that, while not directly activating Ocathepsin, play a crucial role in modulating its activity and ensuring its effective functioning in physiological processes. The presence of essential amino acids like Cysteine is fundamental for Ocathepsin, as it contributes to the active site formation, crucial for the protein's proteolytic function. Similarly, specific inhibitors like E-64 and Z-FA-FMK indirectly enhance Ocathepsin's activity by preventing its premature activation or inactivation, thus preserving its functional integrity for precise physiological roles. Furthermore, selective inhibition of other proteases, as observed with compounds such as Cathepsin B Inhibitor CA-074, Pepstatin A, Phosphoramidon, Leupeptin, Aprotinin, and Bestatin, plays a pivotal role in reducing competitive inhibition. This reduction allows Ocathepsin to process substrates more efficiently, highlighting the significance of protease balance in cellular contexts where Ocathepsin operates.
Additionally, agents like EDTA and Cystatin contribute to this regulatory mechanism. EDTA, by chelating metal ions, limits the activity of metalloproteases, thereby reducing competition for substrates that Ocathepsin might otherwise face. Cystatin, a natural inhibitor of cysteine proteases, further fine-tunes this balance, ensuring a controlled activation of Ocathepsin, which is essential for its involvement in specific physiological processes. Heparin's role in modulating extracellular matrix interactions also indirectly influences Ocathepsin's activity by affecting substrate availability and localization, crucial for its proteolytic functions. Collectively, these Ocathepsin Activators, through their intricate and multifaceted mechanisms, underscore the complex interplay of biochemical factors that govern the activity of proteases like Ocathepsin, emphasizing the nuanced regulation required for their optimal function in biological systems.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
E-64 | 66701-25-5 | sc-201276 sc-201276A sc-201276B | 5 mg 25 mg 250 mg | $281.00 $947.00 $1574.00 | 14 | |
E-64, a cysteine protease inhibitor, can indirectly enhance Ocathepsin's activity by preventing its premature activation, thus preserving its functional integrity for specific physiological roles. | ||||||
CA-074 | 134448-10-5 | sc-202513 | 1 mg | $321.00 | ||
CA-074, specifically inhibiting Cathepsin B, can indirectly enhance Ocathepsin activity by reducing competitive inhibition among cathepsins, allowing for more efficient substrate processing by Ocathepsin. | ||||||
Phosphoramidon | 119942-99-3 | sc-201283 sc-201283A | 5 mg 25 mg | $199.00 $632.00 | 8 | |
Phosphoramidon, a metalloprotease inhibitor, indirectly enhances Ocathepsin's activity by reducing the competition from metalloproteases, thereby allowing Ocathepsin more access to its substrates. | ||||||
Leupeptin hemisulfate | 103476-89-7 | sc-295358 sc-295358A sc-295358D sc-295358E sc-295358B sc-295358C | 5 mg 25 mg 50 mg 100 mg 500 mg 10 mg | $73.00 $148.00 $316.00 $499.00 $1427.00 $101.00 | 19 | |
Leupeptin, a serine and cysteine protease inhibitor, can indirectly enhance Ocathepsin's activity by inhibiting other proteases, thereby reducing substrate competition and preserving Ocathepsin's function. | ||||||
Z-FA-FMK | 197855-65-5 | sc-201303 sc-201303A | 1 mg 5 mg | $128.00 $372.00 | 19 | |
Z-FA-FMK, a cysteine protease inhibitor, indirectly enhances Ocathepsin's activity by preventing the inactivation of Ocathepsin, thus ensuring its availability for physiological processes. | ||||||
Aprotinin | 9087-70-1 | sc-3595 sc-3595A sc-3595B | 10 mg 100 mg 1 g | $112.00 $408.00 $3000.00 | 51 | |
Aprotinin, a serine protease inhibitor, indirectly enhances Ocathepsin's activity by minimizing the interference from serine proteases, allowing Ocathepsin to function more efficiently. | ||||||
Bestatin | 58970-76-6 | sc-202975 | 10 mg | $131.00 | 19 | |
Bestatin, an aminopeptidase inhibitor, indirectly enhances Ocathepsin's activity by reducing competition from aminopeptidases, thereby allowing more effective substrate processing by Ocathepsin. | ||||||